Co-Diagnostics, Inc. Announces Joint Venture in India

SALT LAKE CITY CODX, (BUSINESS WIRE) Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced today the recent incorporation of CoSara Diagnostics, Pvt., Ltd., a Joint Venture for manufacturing with Synbiotics Limited. Synbiotics is a group company of Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets. Co-Diagnostics and Synbiotics incorporated the CoSara entity in India in July. Co-Diagnostics paid
http://bit.ly/2tGJOeZ